INTERNATIONAL PATENT: QIHAN HONG KONG LIMITED FILES APPLICATION FOR "AUTOIMMUNE DISEASE THERAPY USING ENGINEERED CELLS"

GENEVA, Sept. 8 -- QIHAN HONG KONG LIMITED (Rm 1902, Easey Comm. Bldg., 253-261 Hennessy Road, WanchaiHong Kong 999077) filed a patent application (PCT/CN2025/079980) for "AUTOIMMUNE DISEASE THERAPY USING ENGINEERED CELLS" on Feb 28, 2025. With publication no. WO/2025/180514, the details related to the patent application was published on Sep 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PAN, Hongfang (Chuanhuakechuang Mansion B5, Xiaoshan Innovation Polis, Xiaoshan DistrictHangzhou, Zhejiang 311200), HU, Jiapan (Chuanhuakechuang Mansion B5, Xiaoshan Innovation Polis, Xiaoshan DistrictH...